HIV & AIDS

amfAR Study Observes Potential Breakthrough in Treatment of HIV

A new study funded by amfAR, The Foundation for AIDS Research conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important step in the ongoing quest to find a lasting HIV cure. The study, titled(…)

New resource: Paying for PrEP

  The Centers for Disease Control recently published a new brochure explaining how individuals—through a variety of insurance and medication assistance programs—can cover the cost of PrEP. The brochure includes links to a community health center location tool, PrEP assistance programs, and co-pay programs, and gives a breakdown of the steps to take in order(…)

“PrEP: The Revolution That Didn’t Happen” Declares New AHF Ad

A new advocacy ad by the AIDS Healthcare Foundation (AHF) takes aim at the failure of pre-exposure prophylaxis (PrEP), the use of Gilead Sciences’ AIDS treatment Truvada to prevent HIV transmission in uninfected individuals, to catch on despite the fact that the powerful AIDS treatment medication has been approved by the Food and Drug Administration(…)